Cyclooxygenases in reproductive medicine and biology

Journal of the Society for Gynecologic Investigation

Volumn 6, Issue 6, 1999, Pages 285-292

  Kniss, Douglas A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

COX 1; COX 2; Cyclooxygenase; Parturition; Pregnancy; Prostaglandins

Indexed keywords

CARBOCYCLIC THROMBOXANE A2; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; CATALYSIS; CHEMICAL REACTION; CHILDBIRTH; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GLYCOSYLATION; INFLAMMATION; LIPID ANALYSIS; MENSTRUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSGENIC MOUSE;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HUMANS; ISOENZYMES; LABOR, OBSTETRIC; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; PREGNANCY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REPRODUCTION;

EID: 0033431889     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00034-9     Document Type: Review

References (79)

1. Dubois R.N., Abramson S.B., Crofford L., et al. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
2. Davies P., MacIntyre D.E. Prostaglandins and inflammation. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation Basic principles and clinical correlates . 2nd ed. 1992;123-138 Raven Press, Ltd, New York.
3. Keirse M.J.N.C. Eicosanoids in human pregnancy and parturition. Mitchell M.D. Eicosanoids in reproduction. 1990;199-222 CRC Press, Boca Raton.
4. Cameron I.T. Prostaglandins and menstruation. Drife J.O., Calder A.A. Prostaglandins and the uterus. 1992;17-32 Springer-Verlag, London.
5. Smith S.K. Prostaglandins and implantation. Drife J.O., Calder A.A. Prostaglandins and the uterus. 1992;91-99 Springer-Verlag, London.
6. Needleman P., Turk J., Jakschik B.A., Morrison A.R., Lefkowith J.B. Arachidonic acid metabolism. Annu Rev Biochem. 55:1986;69-102.
7. Smith W.L., Marnett L.J. Prostaglandin endoperoxide synthase Structure and catalysis . Biochim Biophys Acta. 1083:1991;1-17.
8. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem J. 259:1989;315-324.
9. Meagher E.A., FitzGerald G.A. The molecular basis of eicosanoid action. Hypertens Pregnancy. 12:1993;439-451.
10. Raz A., Wyche A., Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A. 86:1989;1657-1661.
11. Needleman P., Isakson P.C. The discovery and function of COX-2. J Rheumatol. 24:(Suppl 49):1997;6-8.
12. Xie W., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 88:1991;2692-2696.
13. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 266:1991;12866-12872.
14. O'Banion M.K., Sadowski H.B., Winn V., Young D.A. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem. 266:1991;23261-23267.
15. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
16. Kraemer S.A., Meade E.A., DeWitt D.L. Prostaglandin endoperoxide synthase gene structure Identification of the transcriptional start site and 5′-flanking regulatory sequences . Arch Biochem Biophys. 293:1992;391-400.
17. Wen P.Z., Warden C., Fletcher B.S., Kujubu D.A., Herschman H.R., Lusis A.J. Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse. Genomics. 15:1993;458-460.
18. Egan R.W., Paxton J., Kuehl F.A. Jr. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem. 251:1976;7329-7335.
19. Otto J.C., DeWitt D.L., Smith W.L. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem. 26:1993;18234-18242.
20. Wang L.H., Hjibeigi A., Xu X.M., Loose-Mitchell D., Wu K.K. Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem Biophys Res Commun. 190:1993;406-411.
21. Gou Q., Liu C.H., Ben-Av P., Hla T. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun. 242:1998;508-512.
22. Hansen W.R., Sato T., Mitchell M.D. Tumour necrosis factor-alpha stimulates increased expression of prostaglandin endoperoxide H synthase type 2 mRNA in amnion-derived WISH cells. J Mol Endocrinol. 20:1998;221-231.
23. Herschman H.R., Kujubu D.A., Fletcher B.S., et al. The tis genes, primary response genes induced by growth factors and tumor promoters in 3T3 cells. Prog Nucleic Acids Res Mol Biol. 47:1994;113-148.
24. Adams J., Collaco-Moraes Y., de Belleroche J. Cyclooxygenase-2 induction in cerebral cortex An intracellular response to synaptic excitation . J Neurochem. 66:1996;6-13.
25. Tocco G., Freire-Moar J., Schreiber S.S., Sakhi S.H., Aisen P.S., Pasinetti G.M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain Implications for Alzheimer's disease . Exp Neurol. 144:1997;339-349.
26. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons Regulation by synaptic activity and glucocorticoids . Neuron. 11:1993;371-386.
27. Kaufman W.E., Worley P.F., Pegg J., Bremer M., Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A. 93:1996;2317-2321.
28. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci. 17:1997;2746-2755.
29. Walenga R.W., Kester M., Coroneos E., Butcher S., Dwivedi R., Statt C. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in human tracheal epithelial cells in vitro. Prostaglandins. 52:1996;341-359.
30. Battistini B., Botting R., Bakhle Y.S. COX-1 and COX-2 Toward the development of more selective NSAIDs . Drug News Perspect. 7:1994;501-512.
31. Samet J.M., Fasano M.B., Fonteh A.N., Chilton F.H. Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells. J Biol Chem. 270:1995;8044-8049.
32. Brannon T.S., MacRitchie A.N., Jaramillo M.A., et al. Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung. Am J Physiol. 274:1998;L66-L71.
33. 2. J Biol Chem. 274:1999;11660-11666.
34. Simmons D.L., Xie W., Evett G., Merrill J., Robertson D.L., Bradshaw W.S. Drug inhibition and cellular regulation of prostaglandin G/H synthase isoenzyme 2. J Lipid Med. 6:1993;113-117.
35. Irvine R.F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem J. 204:1982;3-16.
36. Kujubu D.A., Herschman H.R. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem. 267:1992;7991-7994.
37. Newman S.P., Flower R.J., Croxtall J.D. Dexamethasone suppression of IL-1β-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells. Biochem Biophys Res Commun. 202:1994;931-939.
38. Perkins D.J., Kniss D.A. Tumor necrosis factor-α promotes sustained cyclooxygenase-2 expression Attenuation by dexamethasone and NSAIDs . Prostaglandins. 54:1997;727-743.
39. Imseis H.M., Zimmerman P.D., Samuels P., Kniss D.A. Tumour necrosis factor-α induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts Suppression by glucocorticoids and NSAIDs . Placenta. 18:1997;521-526.
40. Zakar T., Olson D.M. Studies on glucocorticoid hormone actions in the regulation of human amnion PGHS. Reprod Fertil Dev. 7:1995;517-520.
41. Simon L.S. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol. 7:1995;159-166.
42. Smith W.L., Meade E.A., DeWitt D.L. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann N Y Acad Sci. 714:1994;136-142.
43. Frolich J.C., Stichtenoth D.O. NSAID Can renal side effects be avoided? Vane J., Botting J., Botting R. Improved non-steroidal anti-inflammatory drugs COX-2 enzyme inhibitors . 1996;203-228 Kluwer Academic Publishers, London.
44. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 271:1996;33157-33160.
45. DeWitt D.L. Cox-2-selective inhibitors The new super aspirin . Mol Pharmacol. 4:1999;625-631.
46. Hawkey C.J. COX-2 inhibitors. Lancet. 353:1999;307-314.
47. Norton M.E., Merrill J., Cooper B.A.B., Kuller J.A., Clyman R.I. Neonatal complications after the administration of indomethacin for preterm labor. New Engl J Med. 329:1993;1602-1607.
48. Gordon M.C., Samuels P. Indomethacin tocolysis-benefits versus risks. Clin Obstet Gynecol. 38:1995;697-705.
49. Ben-David Y., Hallak M., Rotschild A., et al. Indomethacin and fetal ductus arteriosus Complete closure after cessation of prolonged therapeutic course . Fetal Diagn Ther. 11:1996;341-344.
50. Brannon T.S., North A.J., Wells L.B., Shaul P.W. Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest. 93:1994;2230-2235.
51. Sawdy R., Slater D., Fisk N., Edmonds D.K., Bennett P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet. 350:1997;265-266.
52. Smith W.L., DeWitt D.L. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 62:1996;167-215.
53. Seibert K., Masferrer J., Zhang Y., et al. Mediation of inflammation by cyclooxygenase-2. Agents Actions. 46:1995;41-50.
54. Jouzeau J.Y., Terlain B., Abid A., Nedelec E., Netter P. Cyclo-oxygenase isoenzymes How recent findings affect thinking about nonsteroidal anti-inflammatory drugs . Drugs. 53:1997;563-582.
55. Parrett M.L., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P., Robertson F.M. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol. 10:1997;503-507.
56. Levy G.N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
57. Ristimaki A., Honkanen N., Jankala H., Sipponen P., Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57:1997;1276-1280.
58. Yee G.M., Squires P.M., Cejic S.S., Kennedy T.G. Lipid mediators of implantation and decidualization. J Lipid Med. 6:1993;525-534.
59. Marshburn P.B., Shabanowtiz R.B., Clark M.R. Immunohistochemical localization of prostaglandin H synthase in the embryo and uterus of the mouse from ovulation through implantation. Mol Reprod Dev. 25:1990;309-316.
60. Holmes P.V., Sjogren A., Hamberger L. Prostaglandin-E2 released by pre-implantation human conceptuses. J Reprod Immunol. 17:1990;79-86.
61. Kasamo M., Ishidawa M., Yamashita K., Sengoku K., Shimizu T. Possible role of prostaglandin F in blastocyst implantation. Prostaglandins. 31:1986;321-336.
62. Yang Z.M., Das S.K., Wang J., Sugimoto Y., Ichikawa A., Dey S.K. Potential sites of prostaglandin actions in the periimplantation mouse uterus Differential expression and regulation of prostaglandin receptor genes . Biol Reprod. 56:1997;368-379.
63. Wu W.X., Owiny J., Zhang Q., Ma X.H., Nathanielsz P.W. Regulation of the estrogen receptor and its messenger ribonucleic acid in the ovariectomized sheep myometrium and endometrium The role of estradiol and progesterone . Biol Reprod. 55:1996;762-768.
64. Wu W.X., Ma X.H., Zhang Q., Buchwalder L., Nathanielsz P.W. Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo. Endocrinology. 138:1997;4005-4012.
65. Kennard E.A., Zimmerman P.D., Friedman C.I., Kniss D.A. Interleukin-1β induces cyclooxygenase-2 in cultured human decidual cells. Am J Reprod Immunol. 34:1995;65-71.
66. Kniss D.A., Zimmerman P.D., Garver C.L., Fertel R.H. Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium. Am J Obstet Gynecol. 177:1997;559-567.
67. Chakraborty I., Das S.K., Wang J., Dey S.K. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol. 16:1996;107-122.
68. Dong Y.L., Gangula P.R.R., Fang L., Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrus cycle, pregnancy, and in myometrial cells. Prostaglandins. 52:1996;13-34.
69. Langenbach R., Morham S.G., Tiano H.F., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:1995;483-492.
70. Lim H., Paria B.C., Das S.K., et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 91:1997;197-208.
71. Morham S.G., Langenbach R., Loftin C.D., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482.
72. Slater D., Berger L., Newton R., Moore G., Bennett P. The relative abundance of type 1 and type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun. 198:1994;304-308.
73. Gross G.A., Imamura T., Luedke C., et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci U S A. 95:1998;11875-11879.
74. Swaisgood C.M., Zu H.X., Perkins D.J., et al. Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice. Am J Obstet Gynecol. 177:1997;1253-1262.
75. Silver R.M., Edwin S.S., Trautman M.S., et al. Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J Clin Invest. 95:1995;725-731.
76. Kniss D.A., Zimmerman P.D., Gabbe S.G., Iams J.D. Selective ablation of cyclooxygenase-2 gene expression and prostaglandin biosynthesis by antisense phosphorothioates. J Soc Gynecol Invest. 3:(Suppl):1996;95A.
77. Staels B., Koenig W., Habib A., et al. Activation of human aortic smooth-muscle cells is inhibited by PPAR-α but not by PPAR-gamma activators. Nature. 393:1998;790-793.
78. 27 human trophoblasts. J Soc Gynecol Invest. 6:(Suppl):1999;52A.
79. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med. 5:1999;698-701.